|
Volumn 175, Issue 8, 2001, Pages 407-411
|
The impact of specialists on prescribing by general practitioners
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIDEPRESSANT AGENT;
ANTILIPEMIC AGENT;
ATENOLOL;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CILAZAPRIL;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FELODIPINE;
FLUINDOSTATIN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
IRBESARTAN;
LISINOPRIL;
METOPROLOL;
PERINDOPRIL;
PINDOLOL;
PRAVASTATIN;
PROPRANOLOL;
PROTON PUMP INHIBITOR;
QUINAPRIL;
SIMVASTATIN;
ADOLESCENT;
ADULT;
AGED;
ANGINA PECTORIS;
ARTICLE;
CHILD;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG CHOICE;
DRUG INDICATION;
FEMALE;
GENERAL PRACTICE;
GENERAL PRACTITIONER;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MALE;
MEDICAL SPECIALIST;
PRESCRIPTION;
|
EID: 0035886465
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2001.tb143645.x Document Type: Article |
Times cited : (28)
|
References (26)
|